RxDoctor Payments Data

Herbert King, MD

Family Medicine · Midlothian, VANPI 1568414092

Payments from drug & device makers

$11,632in general payments, 2019–2025

Across 781 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$976
  • GSK$632
  • Pfizer$605
  • plus $5K from 50 others

What the payments were for

  • Food & beverage$11,625100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)202$2,475
Amgen(2 entities)74$1,129
Lilly USA, LLC68$1,015
Novo Nordisk64$976
GSK48$632
Pfizer41$605
Boehringer Ingelheim34$589
Takeda Pharmaceuticals U.S.A., Inc.23$378
AstraZeneca22$305
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$272
Merck13$239
Abbott11$192
Teva Pharmaceuticals USA, Inc.10$168
Johnson & Johnson16$158
Biohaven Pharmaceuticals, Inc.7$157
Esperion Therapeutics, Inc.9$155
Amarin Pharma, Inc.7$144
Supernus Pharmaceuticals, Inc.9$135
Eisai Inc.7$116
Inspire Medical Systems, Inc.5$112
Boston Scientific6$103
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$102
Daiichi Sankyo Inc.4$97
Actelion Pharmaceuticals US, Inc.4$84
Kowa Pharmaceuticals America, Inc.6$82
Biohaven Pharmaceutical Holding Company Ltd.4$81
Novartis5$80
Antares Pharma, Inc.3$78
Exact Sciences4$74
Phathom Pharmaceuticals, Inc.5$69
Scpharmaceuticals Inc.3$66
Currax Pharmaceuticals LLC4$63
Astellas Pharma US Inc4$59
Amneal Pharmaceuticals LLC4$57
Dynavax Technologies Corporation2$54
Jazz Pharmaceuticals Inc.3$43
Dexcom, Inc.2$42
Corium, LLC2$42
Ironshore Pharmaceuticals Inc.2$40
Axsome Therapeutics, Inc.2$36
Edwards Lifesciences2$34
Shire North American Group Inc2$32
Endo USA, Inc.1$28
Genentech USA, Inc.2$28
Bard Peripheral Vascular, Inc.1$26
Impulse Dynamics (USA) Inc.1$22
Vanda Pharmaceuticals Inc.1$20
Agios Pharmaceuticals, Inc.1$19
Nalpropion Pharmaceuticals LLC1$16
Ardelyx, Inc.1$16
IBSA Pharma Inc.1$15
Ultragenyx Pharmaceutical Inc.1$14
Mylan Specialty L.p.1$14
Bayer1$14
Tolmar, Inc.1$13
Sanofi-aventis U.S. LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,632 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$96,801
Medicare patients
188
Services billed
1,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$52,781
XareltoRivaroxaban20$32,734
EliquisApixaban33$30,336
RybelsusSemaglutide20$20,478
MounjaroTirzepatide18$18,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$15,064
JardianceEmpagliflozin18$14,218
Repatha SureclickEvolocumab11$10,487
Rosuvastatin Calcium376$4,910
Ezetimibe120$4,108
SymbicortBudesonide/Formoterol Fumarate14$3,667
SynthroidLevothyroxine Sodium58$3,426
Celecoxib58$2,426
Advair DiskusFluticasone Propion/Salmeterol13$1,940
Valsartan37$1,666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$976$73,25967 claims
Johnson & JohnsonXarelto$158$32,73420 claims
PfizerEliquis$605$30,33633 claims
Lilly USA, LLCMounjaro$1,015$18,44518 claims
GSKTrelegy Ellipta$632$15,06423 claims
Boehringer IngelheimJardiance$589$14,21818 claims
AstraZenecaSymbicort$305$3,66714 claims
AbbVieSynthroid$2,475$3,42658 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$57$1,077129 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →